These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 22921523)

  • 41. Methamphetamine-induced dopaminergic neurotoxicity in mice: long-lasting sensitization to the locomotor stimulation and desensitization to the rewarding effects of methamphetamine.
    Itzhak Y; Martin JL; Ali SF
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Oct; 26(6):1177-83. PubMed ID: 12452543
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Methylone-induced hyperthermia and lethal toxicity: role of the dopamine and serotonin transporters.
    Piao YS; Hall FS; Moriya Y; Ito M; Ohara A; Kikura-Hanajiri R; Goda Y; Lesch KP; Murphy DL; Uhl GR; Sora I
    Behav Pharmacol; 2015 Jun; 26(4):345-52. PubMed ID: 25794333
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interactions of dopamine D1 and D2 receptor antagonists with D-methamphetamine-induced hyperthermia and striatal dopamine and serotonin reductions.
    Broening HW; Morford LL; Vorhees CV
    Synapse; 2005 May; 56(2):84-93. PubMed ID: 15714503
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of melatonin on methamphetamine- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity and methamphetamine-induced behavioral sensitization.
    Itzhak Y; Martin JL; Black MD; Ali SF
    Neuropharmacology; 1998 Jun; 37(6):781-91. PubMed ID: 9707292
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and pharmacological characterization of a novel sigma receptor ligand with improved metabolic stability and antagonistic effects against methamphetamine.
    Seminerio MJ; Robson MJ; Abdelazeem AH; Mesangeau C; Jamalapuram S; Avery BA; McCurdy CR; Matsumoto RR
    AAPS J; 2012 Mar; 14(1):43-51. PubMed ID: 22183188
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human immunodeficiency virus-1 Tat protein and methamphetamine interact synergistically to impair striatal dopaminergic function.
    Maragos WF; Young KL; Turchan JT; Guseva M; Pauly JR; Nath A; Cass WA
    J Neurochem; 2002 Nov; 83(4):955-63. PubMed ID: 12421368
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity.
    Itzhak Y; Gandia C; Huang PL; Ali SF
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1040-7. PubMed ID: 9495865
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protective effects of isoliquiritigenin against methamphetamine-induced neurotoxicity in mice.
    Lee MJ; Yang CH; Jeon JP; Hwang M
    J Pharmacol Sci; 2009 Oct; 111(2):216-20. PubMed ID: 19834288
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Methamphetamine-, d-Amphetamine-, and p-Chloroamphetamine-Induced Neurotoxicity Differentially Effect Impulsive Responding on the Stop-Signal Task in Rats.
    Furlong TM; Leavitt LS; Keefe KA; Son JH
    Neurotox Res; 2016 May; 29(4):569-82. PubMed ID: 26846719
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drugs of abuse-induced hyperthermia, blood-brain barrier dysfunction and neurotoxicity: neuroprotective effects of a new antioxidant compound H-290/51.
    Sharma HS; Sjöquist PO; Ali SF
    Curr Pharm Des; 2007; 13(18):1903-23. PubMed ID: 17584116
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tolerance to the neurotoxic effects of methamphetamine in young rats.
    Riddle EL; Kokoshka JM; Wilkins DG; Hanson GR; Fleckenstein AE
    Eur J Pharmacol; 2002 Jan; 435(2-3):181-5. PubMed ID: 11821024
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Markers associated with testosterone enhancement of methamphetamine-induced striatal dopaminergic neurotoxicity.
    Buletko AB; Dluzen DE; McDermott JL; Darvesh AS; Geldenhuys WJ
    Neurotoxicol Teratol; 2012; 34(3):338-43. PubMed ID: 22521941
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tissue plasminogen activator is not involved in methamphetamine-induced neurotoxicity.
    Fukakusa A; Mizoguchi H; Koike H; Nabeshima T; Takuma K; Yamada K
    J Pharmacol Sci; 2008 Feb; 106(2):321-4. PubMed ID: 18277051
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sigma receptor agonists: receptor binding and effects on mesolimbic dopamine neurotransmission assessed by microdialysis.
    Garcés-Ramírez L; Green JL; Hiranita T; Kopajtic TA; Mereu M; Thomas AM; Mesangeau C; Narayanan S; McCurdy CR; Katz JL; Tanda G
    Biol Psychiatry; 2011 Feb; 69(3):208-17. PubMed ID: 20950794
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cortical ionotropic glutamate receptor antagonism protects against methamphetamine-induced striatal neurotoxicity.
    Gross NB; Duncker PC; Marshall JF
    Neuroscience; 2011 Dec; 199():272-83. PubMed ID: 21946008
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Methamphetamine-induced hyperthermia and lethal toxicity: role of the dopamine and serotonin transporters.
    Numachi Y; Ohara A; Yamashita M; Fukushima S; Kobayashi H; Hata H; Watanabe H; Hall FS; Lesch KP; Murphy DL; Uhl GR; Sora I
    Eur J Pharmacol; 2007 Oct; 572(2-3):120-8. PubMed ID: 17673199
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter.
    Fumagalli F; Gainetdinov RR; Valenzano KJ; Caron MG
    J Neurosci; 1998 Jul; 18(13):4861-9. PubMed ID: 9634552
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fragment C Domain of Tetanus Toxin Mitigates Methamphetamine Neurotoxicity and Its Motor Consequences in Mice.
    Mendieta L; Granado N; Aguilera J; Tizabi Y; Moratalla R
    Int J Neuropsychopharmacol; 2016 Aug; 19(8):. PubMed ID: 26945022
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acrylamide increases dopamine levels by affecting dopamine transport and metabolism related genes in the striatal dopaminergic system.
    Pan X; Guo X; Xiong F; Cheng G; Lu Q; Yan H
    Toxicol Lett; 2015 Jul; 236(1):60-8. PubMed ID: 25943760
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Selective blockade of mGlu5 metabotropic glutamate receptors is protective against methamphetamine neurotoxicity.
    Battaglia G; Fornai F; Busceti CL; Aloisi G; Cerrito F; De Blasi A; Melchiorri D; Nicoletti F
    J Neurosci; 2002 Mar; 22(6):2135-41. PubMed ID: 11896153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.